For instance, IFN-β that is commonly used in the treatment of multiple sclerosis based on its downregulatory effects on Th1 cells (T helper cells producing INF-γ) increases anti-AQP4 antibody titers and disease activity in NMO (45, 46). This evidence concerns the gene AQP4 and neuromyelitis optica.